Clinical Trials Regulation | European Medicines Agency (EMA)
...European Union (EU) pharmaceutical legislation known as the Clinical Trials Regulation entered into application on 31 January 2022. It aims to ensure the EU offers an attractive and favourable environment for carrying out clinical research on a large scale, with high standards of public transparency and safety for clinical trial participants....
https://www.ema.europa.eu/en/human-regulatory-overview/research-development/clinical-trials-human-medicines/clinical-trials-regulation
CTIS Evaluation Timelines
...In this document is detailed the timelines for Member States and sponsors in all types of applications within the evaluation of a clinical trial....
https://d142khf7ia35oz.cloudfront.net/-/media/supporting-documents/pink-sheet/2022/10/p1022ema_19.pdf
EU Regulation on Clinical trials | Italian Medicines Agency
...Within the next three years all ongoing trials will transition to the new requirements under the EU Clinical Trial Regulation (CTR)....
https://www.aifa.gov.it/en/regolamento-europeo-sperimentazioni-cliniche
Paul-Ehrlich-Institut - Information on procedures and timelines for ...
...The conduct of a clinical trial in the European Union (EU) is subject to approval pursuant to the Clinical Trials Regulation (EU) No. 536/2014. The regulation divides the approval procedure for clinical trials into the following sections:...
https://www.pei.de/EN/regulation/clinical-trials/procedures-timelines/procedures-timelines-node.html
Clinical Trial Application Timelines Under EU CTR
...This article provides a comprehensive overview of CTA timelines under CTR, focusing on Part I and Part II assessments, CTIS functionality, and sponsor responsibilities in meeting regulatory deadlines....
https://www.clinicalstudies.in/clinical-trial-application-timelines-under-eu-ctr/
Guidance for the Transition of clinical trials from the Clinical Trials ...
...The following questions and answers provide information (i) on the timeline, (ii) on the type of clinical trials that sponsors must transfer to CTIS, and (iii) on the content of the application for mono- and multinational trials....
https://health.ec.europa.eu/system/files/2023-12/transition_ct_dir-reg_guidance_en.pdf
A Guide to the EU Clinical Trial Regulation (CTR) & CTIS
...Defined Timelines: The CTR imposes strict time frames. For a standard trial (non-low-intervention), Member States have 45 days (42 review + 3 clock-stop for sponsor answers) to give an initial decision, plus an extra 12 days to finalise the written decision with or without conditions....
https://intuitionlabs.ai/articles/eu-clinical-trial-regulation-ctr-guide
Clinical Trials in the European Union - EMA
...This website allows you to search clinical trials initiated in the European Union and European Economic Area since 31 January 2022. For clinical trials initiated before 31 January 2022, see the EU Clinical Trials Register....
https://euclinicaltrials.eu/
Reducing review timelines to 60 days - enhancing competitiveness ...
...Several EU countries have launched pilots or established internal processes to reduce approval timelines for (certain types of) mono national CTs, e.g. Germany, Spain, Denmark, Belgium, Austria, Sweden....
https://accelerating-clinical-trials.europa.eu/system/files/2025-09/Reducing%20review%20timelines%20to%2060%20days%20-%20enhancing%20competitiveness%20through%20faster%20CTA%20approval%20-%20Blanca%20Garcia%20Ochoa%20%28EuropaBio%29.pdf
EU Clinical Trial Regulation | Insights | ICON plc
...The European Union Clinical Trials Regulation (EU CTR) 536/20141 came into force on 31st January 2022, with a three-year phased transition period ending 31st January 2025....
https://www.iconplc.com/insights/regulatory-intelligence/eu-clinical-trials-regulation